Showing results (11-20 of 189) with videos related to
Sort By:
Pageof 19
Expert Opinion on Pharmacotherapy|July 18, 2017
The efficacy and safety of adding either vildagliptin or glimepiride to ongoing metformin therapy in patients with type 2 diabetes mellitusGyuri Kim, Sewon Oh, Sang-Man Jin, et al.Kidney Research and Clinical Practice|March 7, 2020
Metformin treatment for patients with diabetes and chronic kidney disease: A Korean Diabetes Association and Korean Society of Nephrology consensus statementKyu Yeon Hur, Mee Kyoung Kim, Seung Hyun Ko, et al.Journal of Cellular Physiology|June 16, 2021
Thiazolidinediones (TZDs) enhance insulin secretory response via GPR40 and adenylate cyclase (AC)Mina Hwang, Hyo-Sup Kim, Sang-Man Jin, et al.Diabetes & Metabolism Journal|February 4, 2024
Safety and Effectiveness of Dulaglutide in the Treatment of Type 2 Diabetes Mellitus: A Korean Real-World Post-Marketing StudyJeonghee Han, Woo Je Lee, Kyu Yeon Hur, et al.Diabetes & Metabolism Journal|February 26, 2020
Metformin Treatment for Patients with Diabetes and Chronic Kidney Disease: A Korean Diabetes Association and Korean Society of Nephrology Consensus StatementKyu Yeon Hur, Mee Kyoung Kim, Seung Hyun Ko, et al.BMC Genomics|March 15, 2019
Transcriptional profiling of PPARα-/- and CREB3L3-/- livers reveals disparate regulation of hepatoproliferative and metabolic functions of PPARαPhilip M M Ruppert, Jong-Gil Park, Xu Xu, et al.BMC Cancer|December 14, 2012
Statins and the risk of gastric cancer in diabetes patientsJeeyun Lee, Soo Hyeon Lee, Kyu Yeon Hur, et al.Autophagy|October 10, 2022
Impaired TFEB activation and mitophagy as a cause of PPP3/calcineurin inhibitor-induced pancreatic β-cell dysfunctionKihyoun Park, Seong Keun Sonn, Seungwoon Seo, et al.Endocrinology and Metabolism (Seoul, Korea)|July 4, 2020
Association of Body Mass Index with the Risk of Incident Type 2 Diabetes, Cardiovascular Disease, and All-Cause Mortality: A Community-Based Prospective StudyJi Cheol Bae, Nam H Cho, Jae Hyeon Kim, et al.Scientific Reports|June 16, 2016
CREBH-FGF21 axis improves hepatic steatosis by suppressing adipose tissue lipolysisJong-Gil Park, Xu Xu, Sungyun Cho, et al.Pageof 19